It is noteworthy that, in esophageal squamous cell carcinoma (ESCC), XIST leads to increased levels of the enhancer of zeste homolog 2 (EZH2) by sequestering miR-101 [83]. This evidence concerns the gene EZH2 and esophageal squamous cell carcinoma.